Norges Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-11,700
| Closed | -$227K | – | 2045 |
|
2023
Q2 | $227K | Hold |
11,700
| – | – | ﹤0.01% | 1991 |
|
2023
Q1 | $332K | Sell |
11,700
-300
| -3% | -$8.51K | ﹤0.01% | 2065 |
|
2022
Q4 | $351K | Hold |
12,000
| – | – | ﹤0.01% | 2105 |
|
2022
Q3 | $317K | Buy |
+12,000
| New | +$317K | ﹤0.01% | 2065 |
|
2021
Q2 | – | Sell |
-85,141
| Closed | -$3.55M | – | 2269 |
|
2021
Q1 | $3.55M | Sell |
85,141
-87,033
| -51% | -$3.63M | ﹤0.01% | 1950 |
|
2020
Q4 | $8.02M | Sell |
172,174
-11,246
| -6% | -$524K | ﹤0.01% | 1810 |
|
2020
Q3 | $7.79M | Sell |
183,420
-35,517
| -16% | -$1.51M | ﹤0.01% | 1789 |
|
2020
Q2 | $10.5M | Sell |
218,937
-4,800
| -2% | -$230K | ﹤0.01% | 1702 |
|
2020
Q1 | $10.3M | Sell |
223,737
-24,442
| -10% | -$1.12M | ﹤0.01% | 1603 |
|
2019
Q4 | $14.9M | Hold |
248,179
| – | – | ﹤0.01% | 1677 |
|
2019
Q3 | $14M | Hold |
248,179
| – | – | ﹤0.01% | 1654 |
|
2019
Q2 | $13.8M | Hold |
248,179
| – | – | ﹤0.01% | 1683 |
|
2019
Q1 | $12.5M | Sell |
248,179
-23,568
| -9% | -$1.19M | ﹤0.01% | 1723 |
|
2018
Q4 | $10.9M | Buy |
271,747
+96,546
| +55% | +$3.89M | ﹤0.01% | 1702 |
|
2018
Q3 | $12.1M | Buy |
175,201
+25,393
| +17% | +$1.76M | ﹤0.01% | 1760 |
|
2018
Q2 | $11.3M | Buy |
149,808
+58,691
| +64% | +$4.44M | ﹤0.01% | 1772 |
|
2018
Q1 | $4.8M | Hold |
91,117
| – | – | ﹤0.01% | 1905 |
|
2017
Q4 | $4.87M | Buy |
91,117
+18,404
| +25% | +$983K | ﹤0.01% | 1874 |
|
2017
Q3 | $4.34M | Sell |
72,713
-64,364
| -47% | -$3.84M | ﹤0.01% | 1885 |
|
2017
Q2 | $10.8M | Buy |
137,077
+21,463
| +19% | +$1.69M | ﹤0.01% | 1708 |
|
2017
Q1 | $9.59M | Buy |
115,614
+44,606
| +63% | +$3.7M | ﹤0.01% | 1749 |
|
2016
Q4 | $5.63M | Hold |
71,008
| – | – | ﹤0.01% | 1839 |
|
2016
Q3 | $4.75M | Buy |
+71,008
| New | +$4.75M | ﹤0.01% | 1879 |
|